
Dermatology
Latest News
Latest Videos

CME Content
More News

Exact triggers in acute urticaria and chronic urticaria are largely unknown, with the success of identifying causes of AU varying between 21-68%.

Previous research has suggested that psoriasis could affect both fecundity and fertility, leading to spontaneous abortion and ectopic pregnancy.

The current registered dosing of the therapy is 30 mg twice daily, but the analyzed dosage of 20 mg has not yet been approved.

Similarly, patients affected by alopecia areata had higher odds of developing psoriasis.

New 5-year data shows psoriasis improvement was similar among patients with and without metabolic syndrome, regardless of which dose they received.

However, comorbidity risk was believed to be substantially different between the two diseases.

EPSOLAY is the first and only micro-encapsulated benzoyl peroxide topical treatment shown to improve inflammatory lesions associated with rosacea

Double board certified dermatologist Dr. Karan Lal details targeted therapies and surgical treatments for vitiligo and how the condition is perceived by different cultures.

Dr. Brett King returns to discuss the impact of JAK inhibitors in the management of atopic dermatitis.

Dr. Sarah Asch details therapeutic strategies for treating pediatric patients with vitiligo.

Key themes such as a distrust in conventional therapies and non-conventional "cures" with no scientific evidence were observed.

Cotton gloves showed superior comfort and practicability among patients with hand dermatoses.

Despite this, investigators noted that patients with ICI-induced bullous pemphigoids experienced relatively improved tumor responses.

The study suggested that dermatologists in academic settings were more likely to utilize teledermatology prior to the limitations of the COVID-19 pandemic as well.

New phase 3 data found that 70% of patients with atopic dermatitis achieved EASI-75 following treatment with lebrikizumab and topical corticosteroids

A new systematic review found that patients with the dermatologic condition experienced moderate impairment of health-related quality of life and emotions.

Conversely, age was shown to have a negative association, as did the highest category of physical activity.

Botulin toxin was first approved by the FDA in 2002 for cosmetic reasons.

Differences in rosacea subtypes were also observed regarding patient sex, continent of origin, and the year of publication.

Dr. Karan Lal provides essential information on rosacea, which the National Rosacea Society estimates to affect 16 million people in the United States.

In data presented at AAD, investigators found increased odds of GERD in patients with rosacea compared to a control group without rosacea.

The investigative team also observed a significant association between psoriasis, IBS, anxiety, and depression in patients with diabetes and rosacea.

Previous research has suggested that current rosacea therapies can also induce burning or stinging sensations in patients.

Among the different rosacea phenotypes included in the study, no statistical difference in ANAs was observed.

The highest epidermal thickness was calculated for Asian skin at the forehead while the lowest epidermal thickness was for African skin at the dorsal forearm.

































































